Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Non-Current Deferred Tax Liability (2022 - 2024)

Updated

Aligos Therapeutics (ALGS) posted Non-Current Deferred Tax Liability of -$1.76 million for Q4 2024, compared with -$2.38 billion a year earlier.

Analysis

Aligos Therapeutics (ALGS) Non-Current Deferred Tax Liability (2022 - 2024) Analysis & Trends

  • In prior years, Aligos Therapeutics' Non-Current Deferred Tax Liability was -$2.38 billion in FY2023 and -$3.17 billion in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.76 Mn
Dec 31, 2023 -2.38 Bn
Dec 31, 2022 -3.17 Bn
API Access

Aligos Therapeutics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ALGS&period=max&api_key=YOUR_API_KEY